Literature DB >> 15247300

Mitochondrial bound hexokinase activity as a preventive antioxidant defense: steady-state ADP formation as a regulatory mechanism of membrane potential and reactive oxygen species generation in mitochondria.

Wagner Seixas da-Silva1, Armando Gómez-Puyou, Marietta Tuena de Gómez-Puyou, Rafael Moreno-Sanchez, Fernanda G De Felice, Leopoldo de Meis, Marcus F Oliveira, Antonio Galina.   

Abstract

Brain hexokinase is associated with the outer membrane of mitochondria, and its activity has been implicated in the regulation of ATP synthesis and apoptosis. Reactive oxygen species (ROS) are by-products of the electron transport chain in mitochondria. Here we show that the ADP produced by hexokinase activity in rat brain mitochondria (mt-hexokinase) controls both membrane potential (Deltapsi(m)) and ROS generation. Exposing control mitochondria to glucose increased the rate of oxygen consumption and reduced the rate of hydrogen peroxide generation. Mitochondrial associated hexokinase activity also regulated Deltapsi(m), because glucose stabilized low Deltapsi(m) values in state 3. Interestingly, the addition of glucose 6-phosphate significantly reduced the time of state 3 persistence, leading to an increase in the Deltapsi(m) and in H(2)O(2) generation. The glucose analogue 2-deoxyglucose completely impaired H(2)O(2) formation in state 3-state 4 transition. In sharp contrast, the mt-hexokinase-depleted mitochondria were, in all the above mentioned experiments, insensitive to glucose addition, indicating that the mt-hexokinase activity is pivotal in the homeostasis of the physiological functions of mitochondria. When mt-hexokinase-depleted mitochondria were incubated with exogenous yeast hexokinase, which is not able to bind to mitochondria, the rate of H(2)O(2) generation reached levels similar to those exhibited by control mitochondria only when an excess of 10-fold more enzyme activity was supplemented. Hyperglycemia induced in embryonic rat brain cortical neurons increased ROS production due to a rise in the intracellular glucose 6-phosphate levels, which were decreased by the inclusion of 2-deoxyglucose, N-acetyl cysteine, or carbonyl cyanide p-trifluoromethoxyphenylhydrazone. Taken together, the results presented here indicate for the first time that mt-hexokinase activity performed a key role as a preventive antioxidant against oxidative stress, reducing mitochondrial ROS generation through an ADP-recycling mechanism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15247300     DOI: 10.1074/jbc.M403835200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  104 in total

1.  Reduction in hexokinase II levels results in decreased cardiac function and altered remodeling after ischemia/reperfusion injury.

Authors:  Rongxue Wu; Kirsten M Smeele; Eugene Wyatt; Yoshihiko Ichikawa; Otto Eerbeek; Lin Sun; Kusum Chawla; Markus W Hollmann; Varun Nagpal; Sami Heikkinen; Markku Laakso; Kentaro Jujo; J Andrew Wasserstrom; Coert J Zuurbier; Hossein Ardehali
Journal:  Circ Res       Date:  2010-11-11       Impact factor: 17.367

2.  Evaluation of Oxidative Stress Parameters and Energy Metabolism in Cerebral Cortex of Rats Subjected to Sarcosine Administration.

Authors:  Rodrigo Binkowski de Andrade; Tanise Gemelli; Denise Bertin Rojas; Tomas Duk Hwa Kim; Ângela Zanatta; Felipe Schmitz; André Felipe Rodrigues; Angela T S Wyse; Moacir Wajner; Carlos Severo Dutra-Filho; Clovis Milton Duval Wannmacher
Journal:  Mol Neurobiol       Date:  2016-06-29       Impact factor: 5.590

3.  Hexokinase cellular trafficking in ischemia-reperfusion and ischemic preconditioning is altered in type I diabetic heart.

Authors:  Ebru Gurel; Savas Ustunova; Aysegul Kapucu; Nadim Yilmazer; Otto Eerbeek; Rianne Nederlof; Markus W Hollmann; Cihan Demirci-Tansel; Coert J Zuurbier
Journal:  Mol Biol Rep       Date:  2013-05-08       Impact factor: 2.316

4.  Dietary fat, fatty acid saturation and mitochondrial bioenergetics.

Authors:  Liping Yu; Brian D Fink; Judith A Herlein; Christine L Oltman; Kathryn G Lamping; William I Sivitz
Journal:  J Bioenerg Biomembr       Date:  2014-02       Impact factor: 2.945

Review 5.  A mitochondrial bioenergetic basis of depression.

Authors:  N Jennifer Klinedinst; William T Regenold
Journal:  J Bioenerg Biomembr       Date:  2014-09-28       Impact factor: 2.945

6.  Intracerebroventricular metformin decreases body weight but has pro-oxidant effects and decreases survival.

Authors:  Luis Valmor Portela; Jussania Gnoatto; Andressa Wigner Brochier; Clarissa Branco Haas; Adriano Martimbianco de Assis; Afonso Kopczynski de Carvalho; Gisele Hansel; Eduardo Rigon Zimmer; Jean Pierre Oses; Alexandre Pastoris Muller
Journal:  Neurochem Res       Date:  2014-12-10       Impact factor: 3.996

7.  Glycolytic enzymes associate dynamically with mitochondria in response to respiratory demand and support substrate channeling.

Authors:  James W A Graham; Thomas C R Williams; Megan Morgan; Alisdair R Fernie; R George Ratcliffe; Lee J Sweetlove
Journal:  Plant Cell       Date:  2007-11-02       Impact factor: 11.277

8.  Mitochondrial creatine kinase activity and phosphate shuttling are acutely regulated by exercise in human skeletal muscle.

Authors:  Christopher G R Perry; Daniel A Kane; Eric A F Herbst; Kazutaka Mukai; Daniel S Lark; David C Wright; George J F Heigenhauser; P Darrell Neufer; Lawrence L Spriet; Graham P Holloway
Journal:  J Physiol       Date:  2012-08-20       Impact factor: 5.182

9.  Partial hexokinase II knockout results in acute ischemia-reperfusion damage in skeletal muscle of male, but not female, mice.

Authors:  Kirsten M Smeele; Otto Eerbeek; Anneke Koeman; Rick Bezemer; Can Ince; Sami Heikkinen; Markku Laakso; Arnold de Haan; Gert Schaart; Maarten R Drost; Markus W Hollmann; Coert J Zuurbier
Journal:  Pflugers Arch       Date:  2010-02-25       Impact factor: 3.657

10.  Genetic variant in HK1 is associated with a proanemic state and A1C but not other glycemic control-related traits.

Authors:  Amélie Bonnefond; Martine Vaxillaire; Yann Labrune; Cécile Lecoeur; Jean-Claude Chèvre; Nabila Bouatia-Naji; Stéphane Cauchi; Beverley Balkau; Michel Marre; Jean Tichet; Jean-Pierre Riveline; Samy Hadjadj; Yves Gallois; Sébastien Czernichow; Serge Hercberg; Marika Kaakinen; Susanne Wiesner; Guillaume Charpentier; Claire Lévy-Marchal; Paul Elliott; Marjo-Riitta Jarvelin; Fritz Horber; Christian Dina; Oluf Pedersen; Robert Sladek; David Meyre; Philippe Froguel
Journal:  Diabetes       Date:  2009-08-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.